Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Chin Neoh, Danny Liew, Monica Slavin, Debbie Marriott, Sharon C A Chen, Orla Morrissey, Kay Stewart, David Kong

Research output: Contribution to journalComment / DebateOther

Abstract

There was an error in this paper. The correct value of life-years (LYs) saved should have been 0.62, rather than 0.53, meaning the incremental cost-effectiveness ratio (ICER) should have been AU$22003/LY saved, rather than AU$25740/LY saved. The revised ICER remains well below the implicit ICER threshold value for cost-effectiveness in Australia (AU$76000/LY saved), and, hence, the conclusion of the study is unchanged. The authors apologize for this error.
Original languageEnglish
Pages (from-to)1052
Number of pages1
JournalJournal of Antimicrobial Chemotherapy
Volume67
Issue number4
DOIs
Publication statusPublished - Apr 2012

Cite this

Neoh, Chin ; Liew, Danny ; Slavin, Monica ; Marriott, Debbie ; Chen, Sharon C A ; Morrissey, Orla ; Stewart, Kay ; Kong, David. / Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis. In: Journal of Antimicrobial Chemotherapy. 2012 ; Vol. 67, No. 4. pp. 1052.
@article{94a9c034079b4abc857b8ca8dc464e11,
title = "Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis",
abstract = "There was an error in this paper. The correct value of life-years (LYs) saved should have been 0.62, rather than 0.53, meaning the incremental cost-effectiveness ratio (ICER) should have been AU$22003/LY saved, rather than AU$25740/LY saved. The revised ICER remains well below the implicit ICER threshold value for cost-effectiveness in Australia (AU$76000/LY saved), and, hence, the conclusion of the study is unchanged. The authors apologize for this error.",
author = "Chin Neoh and Danny Liew and Monica Slavin and Debbie Marriott and Chen, {Sharon C A} and Orla Morrissey and Kay Stewart and David Kong",
year = "2012",
month = "4",
doi = "10.1093/jac/dkr577",
language = "English",
volume = "67",
pages = "1052",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "4",

}

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis. / Neoh, Chin; Liew, Danny; Slavin, Monica; Marriott, Debbie; Chen, Sharon C A; Morrissey, Orla; Stewart, Kay; Kong, David.

In: Journal of Antimicrobial Chemotherapy, Vol. 67, No. 4, 04.2012, p. 1052.

Research output: Contribution to journalComment / DebateOther

TY - JOUR

T1 - Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

AU - Neoh, Chin

AU - Liew, Danny

AU - Slavin, Monica

AU - Marriott, Debbie

AU - Chen, Sharon C A

AU - Morrissey, Orla

AU - Stewart, Kay

AU - Kong, David

PY - 2012/4

Y1 - 2012/4

N2 - There was an error in this paper. The correct value of life-years (LYs) saved should have been 0.62, rather than 0.53, meaning the incremental cost-effectiveness ratio (ICER) should have been AU$22003/LY saved, rather than AU$25740/LY saved. The revised ICER remains well below the implicit ICER threshold value for cost-effectiveness in Australia (AU$76000/LY saved), and, hence, the conclusion of the study is unchanged. The authors apologize for this error.

AB - There was an error in this paper. The correct value of life-years (LYs) saved should have been 0.62, rather than 0.53, meaning the incremental cost-effectiveness ratio (ICER) should have been AU$22003/LY saved, rather than AU$25740/LY saved. The revised ICER remains well below the implicit ICER threshold value for cost-effectiveness in Australia (AU$76000/LY saved), and, hence, the conclusion of the study is unchanged. The authors apologize for this error.

UR - http://www.scopus.com/inward/record.url?scp=84863391286&partnerID=8YFLogxK

U2 - 10.1093/jac/dkr577

DO - 10.1093/jac/dkr577

M3 - Comment / Debate

VL - 67

SP - 1052

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 4

ER -